The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis

OBJECTIVE: Immunological studies have demonstrated a plethora of beneficial effects of dimethyl fumarate (DMF) on various cell types. However, the cellular and molecular targets are incompletely understood and response markers are scarce. Here, we focus on the relation between nuclear factor (erythr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Clin Transl Neurol
Autori principali: Hammer, Anna, Waschbisch, Anne, Kuhbandner, Kristina, Bayas, Antonios, Lee, De‐Hyung, Duscha, Alexander, Haghikia, Aiden, Gold, Ralf, Linker, Ralf A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5989754/
https://ncbi.nlm.nih.gov/pubmed/29928650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.553
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi